How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide - ICIJ
How Merck turned its wonder drug into a blockbuster — and priced o…
1 month ago
icij.org
Merck’s Keytruda Is a $30 Billion Cancer Drug — Are Patients Over-Paying?
Merck’s Keytruda Is a $30 Billion Cancer Drug — Are Patients Over …
1 month ago
childrenshealthdefense.org
Merck braces for Keytruda patent loss with $6.7 billion Terns bet
Merck braces for Keytruda patent loss with $6.7 billion Terns bet
2 months ago
MSN
Merck Announces European Commission Approves KEYTRUDA (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS =1) Platinum-Resistant Recurrent Ovarian Carcinoma
Merck Announces European Commission Approves KEYTRUD…
1 month ago
marketscreener.com
Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
8:11
Merck CEO Rob Davis on FDA approval of Keytruda injection, na…
8 months ago
MSNCNBC
The amount Americans pay for drugs like Keytruda can greatly vary
11:00
The amount Americans pay for drugs like Keytruda can greatly vary
1 month ago
USATODAYKaely Monahan
Merck to create separate cancer business to offset Keytruda patent loss, WSJ reports
Merck to create separate cancer business to offset Keytruda paten…
3 months ago
aol.co.uk
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns
2 months ago
wsj.com
Merck Revamps Pharmaceutical Unit, Creating Separate Cancer Bu…
2 months ago
wsj.com
Merck beats quarterly sales expectations as Keytruda fuels gr…
3 weeks ago
bluewaterhealthyliving.com
Merck Faces Patent Dispute Over New Keytruda Version
Mar 5, 2025
marketscreener.com
Merck plans to launch US subcutaneous version of Keytrud…
10 months ago
bluewaterhealthyliving.com
$
Why Merck’s Keytruda Just Became a Lung Cancer Game Changer
May 11, 2017
FortuneSy Mukherjee
US FDA approves Merck's injectable version of blockbuster cancer ther…
8 months ago
marketscreener.com
Merck share price rises on huge Keytruda sales
Feb 1, 2024
ig.com
Merck Profit Rises on Strong Keytruda Demand
6 months ago
wsj.com
Merck's 1Q profit beats on Keytruda boost
Apr 30, 2019
Fox BusinessFox Business
WSJ: Merck Makes $10 Billion Move as Keytruda Patent Expiration Nears
10 months ago
MSNMichael-Paul Kidd
1:25
Injectable version of cancer drug Keytruda works as well as current …
Nov 19, 2024
MSNCNBC
4:35
Merck's Keytruda gets an upgrade
8 months ago
MSNCNBC
Merck CEO: We're doing the right studies to make KeyTruda broadl…
May 11, 2017
CNBC
0:35
Merck tops earnings estimates on strong demand for Keytruda even …
Oct 31, 2024
CNBC
0:52
Moderna, Merck vaccine with Keytruda delays return of deadly s…
Dec 14, 2023
CNBC
3:16
Merck will have 'a lot more work to do' after Verona deal
12.5K views10 months ago
YahooYahoo Finance Video
Does This Move Make Merck Stock a Buy? - AOL
10 months ago
aol.co.uk
2:00
FDA approves Merck treatment for lung disease, potential path to ups…
Mar 27, 2024
Yahoo
7:57
How Merck reached new ground in the fight against cancer
Jun 5, 2019
YahooYahoo Finance Video
2:19
Merck releases positive data for blockbuster cancer drug
Mar 27, 2025
Yahoo
Merck shells out $10 billion for Verona in bid to diversify beyond …
10 months ago
YahooSabrina Valle,Christy Santhosh
Merck bets on flu prevention with $9.2 billion deal for Cidara Therap…
6 months ago
YahooSriparna Roy
See more videos
Static thumbnail place holder